Close Menu
Shares in both Third Wave Technologies and Sequenom rose sharply in the past five trading days, though neither firm reported any news. Third Wave climbed 17.25 percent to close at $5.98 for the trading period ended Tuesday. Shares in Sequenom, which was the focus of a brief article Monday on the influential investing site The Motley Fool, rose 11.3 percent to close at $3.94.
 
Only three firms in the BCW Index lost value for the week, led by Bruker BioSciences, which fell 3.26 percent.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.